Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleRed Hat
CEO ReviewCompany Review

The Silicon Review Asia

Achieve highest standards and capture the value of automation in biotech through the solutions from the visionary: Dyna Biotech

The Silicon Review
July, 2020


Previously the processes that required analysis, pipetting, and production to be carried out manually are now controlled by automated systems. This did not completely reinvent the segment, instead the automation systems used in operations and mechanical engineering sectors are being optimized and adapted in the life sciences. The biotechnology sector is similar to any other industry as far as the manufacturing processes are automated to produce successful products as quickly as possible, in large quantities. To achieve automation in biotech, experts from most diverse disciplines must maintain a constant dialogue. This will help them to work together successfully.

The Quality standards of Biotech and Pharma industries are an example of the epitome of accuracy and precision. The stringent authorities like WHO, EMEA, JEA, USFDA, etc. are a few examples that ensure zero error tolerance in the process and the end product of the Biopharma manufacturing. For the Biotech and Pharma vaccine/medicine manufacturers, it becomes an incredibly challenging task to comply with the guidelines put forth by these eminent authorities. Dyna Biotech is well aware and understands the manufacturing process and the necessary regulations put forth by WHO, EMEA, JEA, USFDA, and regulations of CGMP. Equipment is manufactured with ASME U stamp, and automation made is with IEC standards. The validation dossier produced is immense compared to the regular fabrication units. Dyna Biotech was established on 1st April 2013 and has been in operation for over seven years at the forefront of manufacturing, validation, installation, and services for a wide range of Biotechnology and Biopharma equipment.

In conversation with Dr. Vinodkumar Patil, CEO and Founder of Dyna Biotech

Q. What are some of the significant challenges you faced in the initial years? How did you overcome them?

If you ask any start-ups, what are the challenges they faced for bringing the business in the action, you will surely be answered that finance, lack of proper organization, difficulty in promotion and sales, budget distribution, etc. Absolutely, these are genuine, but to create a successful set up of Biotech-Pharmaceutical equipment manufacturing company, our team was aligned, creative, hardworking, consistent, and stable for achieving the company's goal. This organizational unity led us to overcome the primary challenges. But still, we have not stopped our approach, we believe practice makes a man perfect. We are an experimental approach based company. We think success is not by chance, it is by accepting the change.

Q. What kind of responses have you received from your clients over the years? How have they motivated you to shape the company’s growth?

We started in 2013, and we are progressing continuously. This is due to the clients located in Pan India, countries like South Korea, Taiwan, Thailand, Bangladesh, Turkey, Germany, and the United States. These clients have a solid relationship with the honest and faithful culture of Dyna Biotech. Appreciation is always connected with motivation, and hence we get a huge thrust for achieving the goals anticipated.

Q. How do you deal with the “never-ending change” in digital transformation?

Training the employees is the key to maintaining ourselves amid the never-ending change. This is the era of the digital revolution, and the pace of changes remains dynamic. Employees are the real asset of the company. If they are not trained within a period of time, it will be of no use. Hence trainings based on the internal and external patterns are always imparted. Our HR Department team always focuses on the key result areas that are required to be improved and accordingly the training set up, it is crated for the development of the employees and ultimate evolution of the company.

Q. What are the factors that help your company to compete on a global platform?

Our clients in countries like South Korea, Taiwan, Thailand, Bangladesh, Turkey, Germany, and the United States have a strong association with the truthful and loyal culture of Dyna Biotech. Hence I established international marketing, sales & service office in Bangkok, Thailand. An eight-member team is working for the vision and mission of the company there. We strongly believe that serving the international market allows us to generate foreign currency for the development of the nation as well as society. This commitment in the sector of healthcare is valuable compassion of Dyna Biotech team towards the national and international society. This makes us matchless and outstanding above all other players in the domestic & international market.

Q. What are your plans for the future development of your company?

Health is an essential aspect of society. For good quality health, we need good quality medicines at an affordable cost. Dyna Biotech is coming up with another subsidiary ‘S V Biotech Pvt Ltd.’ This company will focus on Diagnostics (IVD’s), Fermentation development, R & D for Clients. At present, the setup is ready, and we are ready to start manufacturing. Also, we believe society as an important part of our life.

We want to focus our CSR activities on Tree Plantation, School renovations, employment generation, Industrial training, and visits of college students, Works on Police welfare, etc.

Meet the leader behind the success of Dyna Biotech

Dr. Vinodkumar Patil is a Microbiologist by profession and has completed his education from Maharashtra, India. He has completed his M.Sc. Microbiology and started his career in 1993. He has gained a lot of experience by working for the world’s best Biotech Industries like Lupin, B. Braun Biotech (Germany), Sartorius, Shantha Biotech, and Serum Institute at responsible directive positions. Dr. Vinodkumar also successfully acquired WHO pre-qualification of the pentavalent vaccine for paediatric application at Serum Institute. Dr. Vinodkumar always believed that learning does not stop; this self-stimulus to gain knowledge and experience in the field of biotech benefitted to his clients and partners with many logical marvels. In the years of his professional journey, he simultaneously completed his Ph.D. in the field of science and biotechnology at International Open University. Today, he has an experience of more than two decades starting from clean room design, equipment design, manufacturing, validation and setting up processes for microbial and cell culture products, and he showcases matchless and inspiring expertise. Under the strong leadership of Dr. Vinodkumar, and the team of Dyna Biotech have been rewarded with several awards and accolades like Business Excellence Award, Company of the year Award 2020, Adarsh Udyojag Award, Certificate of Excellence from CEO magazine, Industry Young Academic Entrepreneur Award, Global Asian of the Year 2019-20 Award, Greatest Brand of the year award and the list goes on.

“We are an experimental approach based company. We think success is not by chance, it is by accepting the change.”


Pine Labs Reaffirms its Commitment to Indian Payments Space with Qfix Acquisition

HDFC Bank is Qfix's main distribution partner Pine Labs has announced that it has acquired Qfix, a Mumbai-based online payments startup. This acquisi...

Salesforce Expands into Thailand, Opens Office in Bangkok

Salesforce has announced permanent presence in Thailand by launching its new office in the country’s capital, Bangkok. The permanent presence wi...

GMLL is expected to soon add two more stores to its retail arm ‘Price Mantra’

Garment Mantra Lifestyle, a popular name in the Indian fashion retail segment, recently made an announcement that the company is expanding its retail ...

Tariff plans will cost higher from the next financial year as telecom companies are gearing up to increase rates

The ongoing Covid pandemic had significantly increased the number of mobile and internet users worldwide. The high amount of usage is expected to drop...